[1]
J. Elcheikh, “IMPACT OF PRETRANSPLANT DONOR AND RECIPIENT CYTOMEGALOVIRUS SEROSTATUS ON OUTCOME FOR MULTIPLE MYELOMA PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION.”, Mediterr J Hematol Infect Dis, vol. 5, no. 1, p. e2013026, Apr. 2013.